WNS (NYSE:WNS) issued an update on its FY20 earnings guidance on Thursday morning. The company provided earnings per share guidance of $2.75-2.95 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.80. The company issued revenue guidance of $855-895 million, compared to the consensus revenue estimate of $873.02 million.WNS also updated its FY 2020 guidance to $2.75-2.95 EPS.
WNS stock traded down $0.04 during mid-day trading on Friday, reaching $62.26. The company’s stock had a trading volume of 3,149 shares, compared to its average volume of 143,866. WNS has a 12-month low of $39.24 and a 12-month high of $63.52. The firm has a market cap of $2.97 billion, a P/E ratio of 27.73, a P/E/G ratio of 2.07 and a beta of 1.05. The company has a quick ratio of 2.07, a current ratio of 2.07 and a debt-to-equity ratio of 0.06. The stock has a fifty day moving average of $58.61.
WNS (NYSE:WNS) last released its quarterly earnings data on Thursday, July 18th. The business services provider reported $0.72 earnings per share for the quarter, beating analysts’ consensus estimates of $0.48 by $0.24. WNS had a net margin of 13.04% and a return on equity of 23.64%. The business had revenue of $214.60 million during the quarter, compared to analyst estimates of $207.51 million. During the same period in the previous year, the business earned $0.59 EPS. WNS’s revenue was up 7.4% compared to the same quarter last year. Equities analysts expect that WNS will post 2.3 EPS for the current fiscal year.
WNS has been the subject of a number of recent research reports. Wedbush reiterated an outperform rating and issued a $19.00 price objective on shares of Entasis Therapeutics in a research note on Tuesday, April 2nd. Zacks Investment Research lowered shares of Green Plains from a hold rating to a strong sell rating in a research note on Thursday, June 27th. Cowen reiterated an outperform rating and issued a $70.00 price objective (up from $62.00) on shares of WNS in a research note on Friday. Barrington Research set a $68.00 price objective on shares of WNS and gave the company a buy rating in a research note on Wednesday, July 3rd. Finally, Cantor Fitzgerald lifted their price objective on shares of WNS from $63.00 to $68.00 and gave the company an overweight rating in a research note on Friday. One research analyst has rated the stock with a sell rating, seven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. WNS currently has a consensus rating of Buy and an average price target of $65.13.
WNS (Holdings) Limited, a business process management company, together with its subsidiaries, provides data, voice, analytical, and business transformation services worldwide. It operates through two segments, WNS Global BPM and WNS Auto Claims BPM. The company offers industry-specific services to clients primarily in insurance; travel and leisure; diversified businesses, including manufacturing, retail, consumer packaged goods, media and entertainment, and telecommunication; utilities; consulting and professional services; healthcare; banking and financial services; and shipping and logistics industries.
Featured Article: How does the Federal Reserve determine interest rates?
Receive News & Ratings for WNS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WNS and related companies with MarketBeat.com's FREE daily email newsletter.